Evidence of a Causal Association between Insulinemia and Endometrial Cancer: A Mendelian Randomization Analysis

Journal of the National Cancer Institute

Volumn 107, Issue 9, 2015, Pages

  Nead, Kevin T ^a,b   Sharp, Stephen J ^a   Thompson, Deborah J ^c   Painter, Jodie N ^d   Savage, David B ^e   Semple, Robert K ^e   Barker, Adam ^a   Perry, John R B ^a   Attia, John ^f,g   Dunning, Alison M ^c   Easton, Douglas F ^c   Holliday, Elizabeth ^a,g   Lotta, Luca A ^a   O'Mara, Tracy ^e   McEvoy, Mark ^g   Pharoah, Paul D P ^c   Scott, Rodney J ^f   Spurdle, Amanda B ^e   Langenberg, Claudia ^a   Wareham, Nicholas J ^a   Scott, Robert A ^a,g   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^f JOHN HUNTER HOSPITAL   (Australia)

^g UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; ALLELE; ARTICLE; BODY MASS; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULINEMIA; MAJOR CLINICAL STUDY; MENDELIAN RANDOMIZATION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; BLOOD; COMPLICATION; DIET RESTRICTION; ENDOMETRIAL NEOPLASMS; GENETICS; GENOTYPE; HYPERINSULINISM; METABOLISM; MIDDLE AGED; ODDS RATIO; RISK ASSESSMENT;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; ENDOMETRIAL NEOPLASMS; FASTING; FEMALE; GENOTYPE; HUMANS; HYPERINSULINISM; INSULIN; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 84937827474     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv178     Document Type: Article

References (51)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782-787.
2. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol. 2012;8(4):228-236.
3. Emerging Risk Factors C, Seshasai SR, Kaptoge S, et al. Diabetes mellitus, fasting glucose, and risk of cause-specifc death. N Engl J Med. 2011;364(9):829-841.
4. Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc. 2001;60(1):91-106.
5. Gunter MJ, Hoover DR, Yu H, et al. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(4):921-929.
6. Lukanova A, Zeleniuch-Jacquotte A, Lundin E, et al. Prediagnostic levels of C-peptide, IGF-I, IGFBP-1,-2 and-3 and risk of endometrial cancer. Int J Cancer. 2004;108(2):262-268.
7. Friberg E, Orsini N, Mantzoros CS, et al. Diabetes mellitus and risk of endo-metrial cancer: a meta-analysis. Diabetologia. 2007;50(7):1365-1374.
8. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625-1638.
9. Lawlor DA, Harbord RM, Sterne JA, et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133-1163.
10. Scott RA, Fall T, Pasko D, et al. Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity. Diabetes. 2014;63(12):4378-4387.
11. Scott RA, Lagou V, Welch RP, et al. Large-scale association analyses identify new loci infuencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet. 2012;44(9):991-1005.
12. Voight B F, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identifed through large-scale association analysis. Nat Genet. 2010;42(7):579-589.
13. Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42(2):105-116.
14. Kong A, Steinthorsdottir V, Masson G, et al. Parental origin of sequence variants associated with complex diseases. Nature. 2009;462(7275):868-874.
15. Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981-990.
16. Speliotes EK, Willer CJ, Berndt SI, et al. Association analyses of 249, 796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42(11):937-948.
17. Prokopenko I, Poon W, Magi R, et al. A central role for GRB10 in regulation of islet function in man. PLoS Genet. 2014;10(4):e1004235.
18. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889-894.
19. Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658-665.
20. Rolfe E de L, Loos RJ, Druet C, et al. Association between birth weight and visceral fat in adults. Am J Clin Nutr. 2010;92(2):347-352.
21. Forouhi NG, Luan J, Hennings S, et al. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000. Diabet Med. 2007;24(2):200-207.
22. Ahmad S, Rukh G, Varga T V, et al. Gene x physical activity interactions in obesity: combined analysis of 111, 421 individuals of European ancestry. PLoS Genet. 2013;9(7):e1003607.
23. Spurdle AB, Thompson DJ, Ahmed S, et al. Genome-wide association study identifes a common variant associated with risk of endometrial cancer. Nat Genet. 2011;43(5):451-454.
24. Wellcome Trust Case Control C. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature. 2007;447(7145):661-678.
25. Painter JN, Anderson CA, Nyholt DR, et al. Genome-wide association study identi-fes a locus at 7p15.2 associated with endometriosis. Nat Genet. 2011;43(1):51-54.
26. McEvoy M, Smith W, D'Este C, et al. Cohort profle: The Hunter Community Study. Int J Epidemiol. 2010;39(6):1452-1463.
27. International HapMap Consortium. The International HapMap Project. Nature. 2003;426(6968):789-796.
28. Li Y, Willer C, Sanna S, et al. Genotype imputation. Annu Rev Genomics Hum Genet. 2009;10:387-406.
29. Perry JR, Day F, Elks CE, et al. Parent-of-origin-specifc allelic associations among 106 genomic loci for age at menarche. Nature. 2014;514(7520):92-97.
30. Friedenreich CM, Langley AR, Speidel T P, et al. Case-control study of markers of insulin resistance and endometrial cancer risk. Endocr Relat Cancer. 2012;19(6):785-792.
31. Berstein LM, Kvatchevskaya JO, Poroshina TE, et al. Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer. J Cancer Res Clin Oncol. 2004;130(11):687-693.
32. Maggino T, Pirrone F, Velluti F, et al. The role of the endocrine factors and obesity in hormone-dependent gynecological neoplasias. Eur J Gynaecol Oncol. 1993;14(2):119-126.
33. Kazer RR. Insulin resistance, insulin-like growth factor I and breast cancer: a hypothesis. Int J Cancer. 1995;62(4):403-406.
34. Nestler JE, Powers LP, Matt DW, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the poly-cystic ovary syndrome. J Clin Endocrinol Metab. 1991;72(1):83-89.
35. Quinn MA, Ruffe H, Brown JB, et al. Circulating gonadotrophins and urinary oestrogens in postmenopausal diabetic women. Aust N Z J Obstet Gynaecol. 1981;21(4):234-236.
36. Clarke CL, Sutherland RL. Progestin regulation of cellular proliferation. Endocr Rev. 1990;11(2):266-301.
37. Kataoka N, Cai Q, Xu WH, et al. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene. Cancer. 2007;109(7):1296-1302.
38. Anderson KE, Anderson E, Mink PJ, et al. Diabetes and endometrial cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev. 2001;10(6):611-616.
39. Irwin JC, de las Fuentes L, Dsupin BA, et al. Insulin-like growth factor regulation of human endometrial stromal cell function: coordinate effects on insulin-like growth factor binding protein-1, cell proliferation and prolactin secretion. Regul Pept. 1993;48(1-2):165-177.
40. Murphy LJ. Growth factors and steroid hormone action in endometrial cancer. J Steroid Biochem Mol Biol. 1994;48(5-6):419-423.
41. Ordener C, Cypriani B, Vuillermoz C, et al. Epidermal growth factor and insulin induce the proliferation of guinea pig endometrial stromal cells in serum-free culture, whereas estradiol and progesterone do not. Biol Reprod. 1993;49(5):1032-1044.
42. Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33(7):1674-1685.
43. Pal A, Barber TM, Van de Bunt M, et al. PTEN mutations as a cause of constitutive insulin sensitivity and obesity. N Engl J Med. 2012;367(11):1002-1011.
44. Wong JT, Kim PT, Peacock JW, et al. Pten (phosphatase and tensin homologue gene) haploinsuffciency promotes insulin hypersensitivity. Diabetologia. 2007;50(2):395-403.
45. Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569-578.
46. Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet. 2005;366(9484):491-505.
47. Lurie G, Gaudet MM, Spurdle AB, et al. The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. PLoS One. 2011;6(2):e16756.
48. Delahanty RJ, Beeghly-Fadiel A, Xiang YB, et al. Association of obesity-related genetic variants with endometrial cancer risk: a report from the Shanghai Endometrial Cancer Genetics Study. Am J Epidemiol. 2011;174(10):1115-1126.
49. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endo-metrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1531-1543.
50. Dimas AS, Lagou V, Barker A, et al. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes. 2014;63(6):2158-2171.
51. Palmer TM, Lawlor DA, Harbord RM, et al. Using multiple genetic variants as instrumental variables for modifable risk factors. Stat Methods Med Res. 2012;21(3):223-242.